Virginia U in secretive tobacco deal

Another US university has been found in bed with big tobacco, this time on the down-low. linkurl:The New York Times reported today;http://www.nytimes.com/2008/05/22/us/22tobacco.html?pagewanted=1 that Virginia Commonwealth University entered into a contract with Philip Morris in 2006 that severely restricts researchers' ability to disseminate findings from studies funded by the tobacco company. Tobacco funding in academic research is a contentious issue, with the debate primarily centered arou

Written byAndrea Gawrylewski
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Another US university has been found in bed with big tobacco, this time on the down-low. linkurl:The New York Times reported today;http://www.nytimes.com/2008/05/22/us/22tobacco.html?pagewanted=1 that Virginia Commonwealth University entered into a contract with Philip Morris in 2006 that severely restricts researchers' ability to disseminate findings from studies funded by the tobacco company. Tobacco funding in academic research is a contentious issue, with the debate primarily centered around the linkurl:issue of transparency.;http://www.the-scientist.com/blog/display/54503/ To date, numerous institutions have banned tobacco money from their grants and endowments. The contract between Philip Morris and VCU, which prevents researchers from publishing their results, or even talking about their results, without permission from the company, breaches the university's own rules. Few professors at the university know about the contract, The Times reports. The current amount of grants was not revealed but the paper reported that last year the company gave more than $1 million in grants to the university. "University administrators who are desperate for money will basically do anything they have to for money," Stanton Glantz, University of California researcher and anti-tobacco funding advocate, told the paper. Last year, the UC Board of Regents linkurl:voted down;http://www.the-scientist.com/blog/display/53711/ a ban on tobacco funding.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo